Renhe Pharmacy Co., Ltd.

Shenzhen Stock Exchange 000650.SZ

Renhe Pharmacy Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2023: 1,383,554,874

Renhe Pharmacy Co., Ltd. Shares (Diluted, Weighted) is 1,383,554,874 for the year ending December 31, 2023, a -1.17% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Renhe Pharmacy Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 1,399,938,234, a 0.00% change year over year.
Renhe Pharmacy Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 1,399,938,234, a 11.00% change year over year.
Renhe Pharmacy Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 1,261,261,936, a 1.85% change year over year.
Renhe Pharmacy Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 1,238,340,076, a 0.25% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

Shenzhen Stock Exchange: 000650.SZ

Renhe Pharmacy Co., Ltd.

CEO	Mr. Wujun Huang
IPO Date	Dec. 10, 1996
Location	China
Headquarters	No. 998, Honggu Middle Avenue
Employees	5,792
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Renhe Pharmacy Co., Ltd. produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, topical lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is headquartered in Nanchang, China.

Key trends

Past 5 years